Patents by Inventor Jeanne Wei

Jeanne Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11454189
    Abstract: Methods and systems are provided for reducing hot fuel vapor formation in a port injection fuel rail. In one example, a method may include operating a dual fuel injection system with at least a calibrated minimum amount of port fuel injection over a wide range of engine operating conditions, even as conditions change. A direct fuel injection amount is adjusted in accordance.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: September 27, 2022
    Assignee: Ford Global Technologies, LLC
    Inventors: Stephen George Russ, Joseph Lyle Thomas, Scott Allan Lehto, Christopher Arnold Woodring, Jeanne Wei, David Shelley
  • Patent number: 10022358
    Abstract: The present invention encompasses combinations comprising a plurality of amino acids, formulations thereof for use in humans and animals, as well as methods for increasing muscle protein synthesis, muscle strength, and/or muscle function in a subject with chronic heart failure, cardiac cachexia or a combination thereof.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: July 17, 2018
    Assignee: BioVentures, LLC
    Inventors: Robert R. Wolfe, Jeanne Wei
  • Publication number: 20170143679
    Abstract: The present invention encompasses combinations comprising a plurality of amino acids, formulations thereof for use in humans and animals, as well as methods for increasing muscle protein synthesis, muscle strength, and/or muscle function in a subject with chronic heart failure, cardiac cachexia or a combination thereof.
    Type: Application
    Filed: February 3, 2017
    Publication date: May 25, 2017
    Inventors: Robert R. Wolfe, Jeanne Wei
  • Patent number: 9597367
    Abstract: The present invention encompasses combinations comprising a plurality of amino acids, formulations thereof for use in humans and animals, as well as methods for increasing muscle protein synthesis, muscle strength, and/or muscle function in a subject with chronic heart failure, cardiac cachexia or a combination thereof.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: March 21, 2017
    Assignee: BIOVENTURES, LLC
    Inventors: Robert R. Wolfe, Jeanne Wei
  • Publication number: 20160377019
    Abstract: Methods and systems are provided for reducing hot fuel vapor formation in a port injection fuel rail. In one example, a method may include operating a dual fuel injection system with at least a calibrated minimum amount of port fuel injection over a wide range of engine operating conditions, even as conditions change. A direct fuel injection amount is adjusted in accordance.
    Type: Application
    Filed: April 21, 2016
    Publication date: December 29, 2016
    Inventors: Stephen George Russ, Joseph Lyle Thomas, Scott Allan Lehto, Christopher Arnold Woodring, Jeanne Wei, David Shelley
  • Patent number: 9365856
    Abstract: The present invention encompasses methods of administering SRF?3. Administering SRF?3 may reduce proliferation of cancer cells, and modulate activity of promoters regulated by serum response factor.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: June 14, 2016
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Jeanne Wei, Gohar Azhar, Xiaomin Zhang
  • Publication number: 20140315788
    Abstract: The present invention encompasses combination comprising a plurality of amino acids, formulations thereof for use in humans and animals, as well as methods for increasing muscle protein synthesis, muscle strength, and/or muscle function.
    Type: Application
    Filed: April 18, 2014
    Publication date: October 23, 2014
    Inventors: Robert R. Wolfe, Jeanne Wei
  • Publication number: 20140080123
    Abstract: The present invention encompasses methods of administering SRF?3. Administering SRF?3 may reduce proliferation of cancer cells, and modulate activity of promoters regulated by serum response factor.
    Type: Application
    Filed: September 16, 2013
    Publication date: March 20, 2014
    Inventors: Jeanne Wei, Gohar Azhar, Xiaomin Zhang
  • Publication number: 20080009605
    Abstract: The invention provides isolated p49/STRAP protein, and isolated nucleic acids encoding a p49/STRAP protein. The inventors have discovered a new protein, named p49/STRAP that is expressed in cardiac tissue and other tissues in mammals. The p49/STRAP protein binds to serum response factor (SRF) and regulates transcription of SRF-responsive genes in the heart. p49/STRAP is also discovered to inhibit tumor cell proliferation, and thus the invention provides a method of inhibiting cancer cell proliferation by contacting the cells with p49/STRAP.
    Type: Application
    Filed: March 22, 2007
    Publication date: January 10, 2008
    Applicant: The Board of Trustees of the University of Arkansas
    Inventors: Jeanne Wei, Xiaomin Zhang
  • Publication number: 20060058237
    Abstract: The invention provides isolated p49/STRAP protein, and isolated nucleic acids encoding a p49/STRAP protein. The inventors have discovered a new protein, named p49/STRAP that is expressed in cardiac tissue and other tissues in mammals. The p49/STRAP protein binds to serum response factor (SRF) and regulates transcription of SRF-responsive genes in the heart. p49/STRAP is also discovered to inhibit tumor cell proliferation, and thus the invention provides a method of inhibiting cancer cell proliferation by contacting the cells with p49/STRAP.
    Type: Application
    Filed: September 13, 2005
    Publication date: March 16, 2006
    Applicant: Board of Trustees of the University of Arkansas
    Inventors: Jeanne Wei, Xiaomin Zhang